WET AGE-RELATED MACULAR DEGENERATION
Clinical trials for WET AGE-RELATED MACULAR DEGENERATION explained in plain language.
Never miss a new study
Get alerted when new WET AGE-RELATED MACULAR DEGENERATION trials appear
Sign up with your email to follow new studies for WET AGE-RELATED MACULAR DEGENERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Vision-Saving injection tested against standard for blinding eye disease
Disease control CompletedThis study tested if a new eye injection called JL14002 works as well as the standard treatment (ranibizumab/Lucentis) for wet age-related macular degeneration, a leading cause of vision loss in older adults. 443 patients received either the new injection or the standard one ever…
Matched conditions: WET AGE-RELATED MACULAR DEGENERATION
Phase: PHASE3 • Sponsor: Jecho Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Eye drop for blinding disease gets first human safety check
Disease control CompletedThis was an early-stage study to see if a new eye drop called SCAI-005 is safe for people. Researchers gave the drops to 48 healthy Korean adults to check for side effects and measure how the drug moves through the body. The goal is to develop a potential new treatment for wet ag…
Matched conditions: WET AGE-RELATED MACULAR DEGENERATION
Phase: PHASE1 • Sponsor: SCAI Therapeutics • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
Eye implant aims to reduce injections for blinding eye disease
Disease control CompletedThis study tested a new, long-acting eye implant called EYP-1901 for people with wet age-related macular degeneration (AMD), a leading cause of vision loss. The goal was to see if the implant, which slowly releases medicine, could work as well as or better than the standard treat…
Matched conditions: WET AGE-RELATED MACULAR DEGENERATION
Phase: PHASE2 • Sponsor: EyePoint Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 09, 2026 14:26 UTC
-
AI eye test lets patients check vision at home
Diagnosis CompletedThis study tested a new, more affordable eye-tracking device called CRYSTALSIGHT that uses artificial intelligence. It was designed to help patients with macular diseases, like age-related macular degeneration, monitor their vision from home. Researchers compared it to a standard…
Matched conditions: WET AGE-RELATED MACULAR DEGENERATION
Sponsor: Tan Tock Seng Hospital • Aim: Diagnosis
Last updated Mar 25, 2026 14:08 UTC